Drug Trial Radar · NCT06171607
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
Last checked: Nov 20, 2026Latest source record: Feb 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Nov 5, 2020
Primary completion
Nov 5, 2026
Study completion Nov 5, 2027
Sponsor
- Lead sponsor
- University of Southern CaliforniaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Dec 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical trial investigates the role of contrast enhanced ultrasound (CEUS) in identifying cystic breast masses as benign or malignant. Ultrasound is a diagnostic imaging test that uses sound waves to make pictures of the body without using radiation (x-rays). Ultrasounds are widely used to diagnose many diseases in the body. This trial may help researchers learn if using CEUS will help in determining whether or not an ultrasound guided biopsy is necessary.
Conditions
- Breast Carcinoma
Interventions
Contrast-Enhanced UltrasoundProcedure
Undergo CEUS
Perflutren Lipid MicrospheresDrug
Given IV
Sulfur Hexafluoride Lipid MicrospheresDrug
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Radiomics-based ML-classifier frameworkTime frame: Up to 12 months
- Performance of radiomics-based ML approach to prevent unnecessary biopsiesTime frame: Up to 12 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Los Angeles County-USC Medical Center
Los Angeles, California · Recruiting
USC / Norris Comprehensive Cancer Center
Los Angeles, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.